
Expand
JoachimKohler-HB · CC BY-SA 4.0 · Wikimedia Commons
Updated
Novartis raised its peak sales forecasts for blockbuster drugs to $18 billion, CNBC Top News reported on November 19, 2026, citing strong demand. The upgrades cover medicines for multiple sclerosis, leukemia and cholesterol. The company is seeking to show that its growth can last. The available excerpt gave no share price reaction or revised figures for individual products.
Sources:CNBC Top News